Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. From Wikipedia
The trades signal a concentrated, short-window tilt toward crypto‑exposed platforms across ARK’s actively managed ETFs.
